Meet the Plain Language Planning Team
Kathy Weil has been appointed as the Senior Policy Analyst to lead the implementation of the Plain Writing Act throughout the agency. In this essential position, she is responsible for ensuring that FDA meets the mandates of the Act and that all employees have the training, tools, and resources to incorporate Plain Language Principles into their public communication. Ms. Weil leads the Plain Language Workgroup consisting of FDA employees whose contributions to implementing this Act are critical to its success. Her personal goal is to ensure that Plain Language Principles become an expected, integral, and sustainable part of FDA’s culture. Ms. Weil has worked at FDA since 2006 as an analyst, consumer safety officer, and branch chief. She holds a Bachelors in Nursing and Masters in Applied Communication, has practiced clinically, as a clinical research coordinator, and was both a medical writer and managing editor for a national medical publishing company.
Julie Frandsen is a Junior Policy Analyst in the Office of the Executive Secretariat, where she has worked since June 2008. Ms. Frandsen plays a key role in implementing Plain Language throughout the FDA. She has also been involved in plain language activities both inside the FDA and with other government agencies through Plain Language conferences, training sessions, and committees. Her other duties include posting the public calendar to FDA.gov and compiling the FDA Weekly Report. She has ten years’ experience as a writer/editor including contracting support for the National Institutes of Health at the National Cancer Institute’s Office of Public Inquiries and the National Institute of Neurological Disorders and Stroke’s Office of Communications. Her education includes a Bachelor’s of Arts in International Relations and a Technical Writing Certificate.